Virtus Biotech Clinical Trials Etf is a ETF series of ETFis Series Trust I (series S000047353). Net assets $37.3M as of 2026-04-30. Index fund.
Showing 15 of 125 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| DREYFUS GOVERNMENT CASH MANAGE | DGCXX | $852K | 228.26% |
| ERASCA INC | — | $817K | 218.70% |
| ENLIVEN THERAPEUTICS INC | — | $675K | 180.78% |
| TANGO THERAPEUTICS INC | — | $638K | 170.94% |
| ORUKA THERAPEUTICS INC | — | $625K | 167.53% |
| SPYRE THERAPEUTICS INC | — | $611K | 163.68% |
| ALUMIS INC | — | $593K | 158.85% |
| DIANTHUS THERAPEUTICS INC | — | $575K | 154.06% |
| KODIAK SCIENCES INC | — | $504K | 134.99% |
| REVOLUTION MEDICINES INC | — | $504K | 134.95% |
| CORVUS PHARMACEUTICALS INC | — | $501K | 134.17% |
| REZOLUTE INC | — | $491K | 131.43% |
| DEFINIUM THERAPEUTICS INC | — | $481K | 128.89% |
| CG ONCOLOGY INC | — | $450K | 120.50% |
| JADE BIOSCIENCES INC | — | $450K | 120.42% |
| Report date | Net assets |
|---|---|
| 2026-04-30 | $37.3M |
| 2026-01-30 | $36.8M |
| 2025-10-31 | $21.0M |
| 2025-07-31 | $15.1M |
| 2025-04-30 | $15.3M |
| 2025-01-31 | $6.9M |
| 2024-10-31 | $11.3M |
| 2024-07-31 | $11.5M |